Matthew John Toth

Title: Innovations and Contributions of Matthew John Toth

Introduction

Matthew John Toth is an accomplished inventor based in Iselin, NJ (US). He has made significant contributions to the field of biomedical research, particularly in the study of genetic diseases. With a total of 2 patents, Toth's work has the potential to impact the treatment of serious health conditions.

Latest Patents

Toth's latest patents include a mouse model for Pompe disease and methods of use thereof. This invention provides valuable mouse models for Pompe disease, allowing researchers to test agents that may be effective in its treatment. Another notable patent is related to DNA coding sequences for mevalonate pyrophosphate decarboxylase. This patent details the cloning and expression of the cDNA for human liver mevalonate pyrophosphate decarboxylase, an enzyme involved in the cholesterol synthesis pathway. The cDNA encodes a 400 amino acid protein that resembles the coding sequence of an unidentified open reading frame adjacent to the COQ2 gene of Saccharomyces cerevisiae.

Career Highlights

Throughout his career, Toth has worked with prominent companies in the pharmaceutical and biotechnology sectors. He has been associated with Amicus Therapeutics, Inc. and Novartis Finance Corporation, where he contributed to various innovative projects aimed at advancing medical science.

Collaborations

Toth has collaborated with notable professionals in his field, including Richie Khanna and Leslie Robin Huwyler. These collaborations have further enriched his research and development efforts.

Conclusion

Matthew John Toth's contributions to biomedical research through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of genetic diseases.